CSF1R and neoplasm: In vivo and in vitro experiments have demonstrated that growth suppression of tumor-associated macrophages (TAMs) through inhibition of colony-stimulating factor 1 receptor (CSF1R) can improve the anti-tumor, pro-inflammatory function of macrophages and enhance tumor immunogenicity for optimal ICI synergy [28].